Histamine and histamine intolerance

被引:556
作者
Maintz, Laura [1 ]
Novak, Natalija [1 ]
机构
[1] Univ Bonn, Dept Dermatol, D-53105 Bonn, Germany
关键词
histamine intolerance; histamine; diamine oxidase; food intolerance; allergy;
D O I
10.1093/ajcn/85.5.1185
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Histamine intolerance results from a disequilibrium of accumulated histamine and the capacity for histamine degradation. Histamine is a biogenic amine that occurs to various degrees in many foods. In healthy persons, dietary histamine can be rapidly detoxified by amine oxidases, whereas persons with low amine oxidase activity are at risk of histamine toxicity. Diamine oxidase (DAO) is the main enzyme for the metabolism of ingested histamine. It has been proposed that DAO, when functioning as a secretory protein, may be responsible for scavenging extracellular histamine after mediator release. Conversely, histamine N-methyltransferase, the other important enzyme inactivating histamine, is a cytosolic protein that can convert histamine only in the intracellular space of cells. An impaired histamine degradation based on reduced DAO activity and the resulting histamine excess may cause numerous symptoms mimicking an allergic reaction. The ingestion of histamine-rich food or of alcohol or drugs that release histamine or block DAO may provoke diarrhea, headache, rhinoconjunctival symptoms, asthma, hypotension, arrhythmia, urticaria, pruritus, flushing, and other conditions in patients with histamine intolerance. Symptoms can be reduced by a histamine-free diet or be eliminated by antihistamines. However, because of the multifaceted nature of the symptoms, the existence of histamine intolerance has been underestimated, and further studies based on double-blind, placebo-controlled provocations are needed. In patients in whom the abovementioned symptoms are triggered by the corresponding substances and who have a negative diagnosis of allergy or internal disorders, histamine intolerance should be considered as an underlying pathomechanism.
引用
收藏
页码:1185 / 1196
页数:12
相关论文
共 135 条
[1]   HEADACHE PROVOCATION BY CONTINUOUS INTRAVENOUS-INFUSION OF HISTAMINE - CLINICAL-RESULTS AND RECEPTOR MECHANISMS [J].
AEBELHOLTKRABBE, A ;
OLESEN, J .
PAIN, 1980, 8 (02) :253-259
[2]  
Ahrens F, 2002, INFLAMM RES, V51, pS83
[3]  
[Anonymous], 1996, BIOGENE AMINE ERNAHR
[4]  
ASCHENBACH JR, 1998, Z GASTROENTEROL S1, V36, P12
[5]  
BACKHAUS B, 2005, ALLERGO J, V14, P41
[6]   Effects of unfractionated and low molecular weight heparins on diamine oxidase release [J].
Biebl, M ;
Klocker, J ;
Perkmann, R ;
Mühlthaler, H ;
Kolbitsch, C ;
Fraedrich, G ;
Schwelberger, HG .
INFLAMMATION RESEARCH, 2003, 52 (Suppl 1) :S63-S64
[7]  
Biebl M, 2002, INFLAMM RES, V51, pS93
[8]  
BIECK PR, 1988, J CLIN PSYCHOPHARM, V8, P237
[9]   DISTRIBUTION AND PROPERTIES OF HUMAN INTESTINAL DIAMINE OXIDASE AND ITS RELEVANCE FOR THE HISTAMINE CATABOLISM [J].
BIEGANSKI, T ;
KUSCHE, J ;
LORENZ, W ;
HESTERBERG, R ;
STAHLKNECHT, CD ;
FEUSSNER, KD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 756 (02) :196-203
[10]   INHIBITION OF PLANT AND MAMMALIAN DIAMINE OXIDASE BY SUBSTRATE-ANALOGS [J].
BIEGANSKI, T ;
OSINSKA, Z ;
MASLINSKI, C .
AGENTS AND ACTIONS, 1982, 12 (1-2) :41-46